Zhixiang Jian

1.2k total citations
38 papers, 781 citations indexed

About

Zhixiang Jian is a scholar working on Oncology, Surgery and Hepatology. According to data from OpenAlex, Zhixiang Jian has authored 38 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 18 papers in Surgery and 12 papers in Hepatology. Recurrent topics in Zhixiang Jian's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers) and Pancreatic and Hepatic Oncology Research (9 papers). Zhixiang Jian is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers) and Pancreatic and Hepatic Oncology Research (9 papers). Zhixiang Jian collaborates with scholars based in China, Taiwan and United States. Zhixiang Jian's co-authors include Haosheng Jin, Ye Lin, Min Yu, Baohua Hou, Zi Yin, Liang Chang, Renguo Guan, Shiye Ruan, Yiping Zou and Weifeng Hong and has published in prestigious journals such as Frontiers in Immunology, Medicine and Annals of Surgical Oncology.

In The Last Decade

Zhixiang Jian

38 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhixiang Jian China 17 335 231 211 206 195 38 781
Mariko Tsukagoshi Japan 18 467 1.4× 288 1.2× 180 0.9× 228 1.1× 158 0.8× 108 956
Takayoshi Kaida Japan 16 401 1.2× 273 1.2× 143 0.7× 159 0.8× 127 0.7× 44 761
Norihiro Ishii Japan 17 389 1.2× 292 1.3× 140 0.7× 193 0.9× 248 1.3× 114 1.0k
Kohei Shigeta Japan 15 590 1.8× 260 1.1× 210 1.0× 139 0.7× 134 0.7× 75 945
Takamichi Igarashi Japan 16 355 1.1× 203 0.9× 124 0.6× 142 0.7× 139 0.7× 94 691
Kyohei Yugawa Japan 16 301 0.9× 195 0.8× 159 0.8× 215 1.0× 174 0.9× 41 703
Monica Lencioni Italy 16 446 1.3× 200 0.9× 214 1.0× 140 0.7× 263 1.3× 51 791
Sang Soo Kim South Korea 18 255 0.8× 185 0.8× 283 1.3× 288 1.4× 212 1.1× 45 845
Jun‐Hua Lu China 17 267 0.8× 367 1.6× 214 1.0× 269 1.3× 400 2.1× 33 1.0k
N. Chatzizacharias United Kingdom 14 264 0.8× 238 1.0× 154 0.7× 115 0.6× 85 0.4× 64 639

Countries citing papers authored by Zhixiang Jian

Since Specialization
Citations

This map shows the geographic impact of Zhixiang Jian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhixiang Jian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhixiang Jian more than expected).

Fields of papers citing papers by Zhixiang Jian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhixiang Jian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhixiang Jian. The network helps show where Zhixiang Jian may publish in the future.

Co-authorship network of co-authors of Zhixiang Jian

This figure shows the co-authorship network connecting the top 25 collaborators of Zhixiang Jian. A scholar is included among the top collaborators of Zhixiang Jian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhixiang Jian. Zhixiang Jian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zou, Yiping, et al.. (2023). Construction and validation of chemoresistance-associated tumor- infiltrating exhausted-like CD8+ T cell signature in breast cancer: cr-TILCD8TSig. Frontiers in Immunology. 14. 1120886–1120886. 6 indexed citations
2.
Guan, Renguo, et al.. (2022). Microvascular Invasion in Hepatocellular Carcinoma: A Review of Its Definition, Clinical Significance, and Comprehensive Management. Journal of Oncology. 2022. 1–10. 33 indexed citations
3.
Guan, Renguo, Yiping Zou, Zhixiang Jian, et al.. (2022). Nomogram Based on Inflammatory Biomarkers to Predict the Recurrence of Hepatocellular Carcinoma—A Multicentre Experience. Journal of Inflammation Research. Volume 15. 5089–5102. 13 indexed citations
4.
Lin, Shuwen, et al.. (2021). Meta-analysis of the prognostic value of pretreatment serum ferritin in hepatobiliary and pancreas (HBP) cancers. BMJ Open. 11(5). e040801–e040801. 5 indexed citations
5.
Shi, Ning, Yiping Zou, Lin Ye, et al.. (2021). Functional anatomical hepatectomy guided by indocyanine green fluorescence imaging in patients with localized cholestasis: Report of four cases. World Journal of Gastrointestinal Surgery. 13(3). 323–329. 3 indexed citations
6.
Lin, Shuwen, et al.. (2020). Prognostic value of lymphocyte to monocyte ratio in pancreatic cancer: a systematic review and meta-analysis including 3338 patients. World Journal of Surgical Oncology. 18(1). 186–186. 19 indexed citations
7.
Jin, Liang, Ning Shi, Shiye Ruan, et al.. (2020). The role of intraoperative radiation therapy in resectable pancreatic cancer: a systematic review and meta-analysis. Radiation Oncology. 15(1). 76–76. 9 indexed citations
8.
Wang, Huiling, et al.. (2019). Complication Analysis with Percutaneous Postoperative Choledochoscopy in 826 Patients: A Single-Center Study. Journal of Laparoendoscopic & Advanced Surgical Techniques. 29(8). 995–999. 3 indexed citations
10.
Yu, Min, Weifeng Hong, Shiye Ruan, et al.. (2019). Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer. Frontiers in Oncology. 9. 773–773. 27 indexed citations
11.
Wang, Huiling, et al.. (2019). Contrast of therapeutic effects between CBD incision and LLHD stump in biliary tract exploration of LLS for hepatolithiasis. Surgical Endoscopy. 34(2). 915–919. 4 indexed citations
12.
Zhang, Chuanzhao, Yanxia Wu, Hongkai Zhuang, et al.. (2019). <p>Establishment and validation of an AJCC stage- and histologic grade-based nomogram for pancreatic neuroendocrine tumors after surgical resection</p>. Cancer Management and Research. Volume 11. 7345–7352. 10 indexed citations
13.
14.
Yin, Zi, Haosheng Jin, Tingting Ma, et al.. (2018). Laparoscopic hepatectomy versus open hepatectomy in the management of posterosuperior segments of the Liver: A systematic review and meta-analysis. International Journal of Surgery. 60. 101–110. 10 indexed citations
15.
Yin, Zi, Yu Zhou, Baohua Hou, et al.. (2018). Revision of Surgical Margin under Frozen Section to Achieve R0 Status on Survival in Patients with Pancreatic Cancer. Journal of Gastrointestinal Surgery. 22(9). 1565–1575. 5 indexed citations
17.
Chang, Liang, et al.. (2017). SIRT5 promotes cell proliferation and invasion in hepatocellular carcinoma by targeting E2F1. Molecular Medicine Reports. 17(1). 342–349. 64 indexed citations
18.
Chen, Sheng, Ning Na, & Zhixiang Jian. (2017). Pretreatment platelet count as a prognostic factor in patients with pancreatic cancer: a systematic review and meta-analysis. OncoTargets and Therapy. Volume 11. 59–65. 18 indexed citations
19.
He, Guolin, Yuan Cheng, Chenjie Zhou, et al.. (2015). Tripartite comparison of single-incision and conventional laparoscopy in cholecystectomy: A multicenter trial. World Journal of Gastrointestinal Endoscopy. 7(5). 540–540. 12 indexed citations
20.
Fang, Chihua, et al.. (2008). Surgical Management and Prognostic Factors of Hilar Cholangiocarcinoma: Experience with 115 Cases in China. Annals of Surgical Oncology. 15(8). 2113–2119. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026